A randomized, open‐label, active comparator trial assessing the effects of 26 weeks of liraglutide or sitagliptin on cardiovascular function in young obese adults with type 2 diabetes
2020 ◽
Vol 22
(7)
◽
pp. 1187-1196
◽
Keyword(s):
2020 ◽
Keyword(s):
2020 ◽
Keyword(s):
2020 ◽
Keyword(s):
2020 ◽
Keyword(s):
2020 ◽
Keyword(s):
2020 ◽
Keyword(s):
2020 ◽
Keyword(s):
2016 ◽
Vol 18
(8)
◽
pp. 803-811
◽
Keyword(s):
Keyword(s):
Keyword(s):